ATI RN Pharmacology 2023 III | Nurselytic

Questions 69

ATI RN

ATI RN Test Bank

ATI RN Pharmacology 2023 III Questions

Extract:


Question 1 of 5

A nurse is planning care for a group of clients. Which of the following client's medications should be monitored by the nurse for hearing loss related to a medication interaction?

Correct Answer: B

Rationale: The correct answer is B: Furosemide and amikacin. Furosemide is a loop diuretic known to cause ototoxicity, which can lead to hearing loss. When combined with amikacin, an aminoglycoside antibiotic also known for its potential ototoxic effects, the risk of hearing loss is increased. Monitoring these medications for any signs of hearing impairment is crucial to prevent permanent damage.



Choices A, C, and D do not typically cause hearing loss as a side effect or through interactions. Propranolol, raloxifene, digoxin, levothyroxine, losartan, and atorvastatin are not associated with ototoxicity. Monitoring these medications for hearing loss related to medication interactions is not necessary.

Question 2 of 5

Correct Answer:

Rationale:

Question 3 of 5

Correct Answer:

Rationale:

Question 4 of 5

Correct Answer:

Rationale:

Question 5 of 5

Correct Answer:

Rationale:

Similar Questions

Access More Questions!

ATI RN Basic


$89/ 30 days

 

ATI RN Premium


$150/ 90 days